Skip to main content

FDA recall, , Low risk

Meitheal Pharmaceuticals Vecuronium Bromide for Injection

Vecuronium Bromide for Injection lacks a warning or Rx legend on its label.

What happened

Meitheal Pharmaceuticals, Inc., of Chicago, Illinois, is voluntarily recalling Vecuronium Bromide for Injection because the label lacks a warning or Rx legend. The FDA has added the recall to its Enforcement Report as of October 29, 2026, and the agency classified it that same day.

The product was distributed nationwide in the United States. The recall began on October 8, 2026, and customers were notified by letter.

2 photos

What to do

The FDA notice gives no instructions for this recall. FDA's general advice for medicine recalls:

  1. Check the FDA or company notice for instructions specific to this product.
  2. Ask your pharmacist or doctor whether your lot is affected and what to do.

Is yours affected?

Match your product and all the details in one listed combination.

An NDC (National Drug Code) is usually printed on the drug's label.

  1. Vecuronium Bromide for Injection

    1. Strength
      10 mg
      NDC
      • 71288-744-11
      Lot code
      • T1P0213A
      • T1P0313A
      • T1P0412A
      • T1P0413A
      • T1P0512A
      • T1P0513A
    2. Strength
      20 mg
      NDC
      • 71288-745-21
      Lot code
      • T1P0113C
      • T1P0612C

Recall details

Posted by FDA
Recall began
Status
Open
Sold in

US. Nationwide

Recalled by
Meitheal Pharmaceuticals, IncChicago, Illinois
Risk

Low risk

Taking it is unlikely to cause health problems.

FDA Class III recall · How risk is rated

FDA event number
100110
Recall numbers
D-0108-2027 to D-0109-2027
Recall type
Voluntary: Firm initiated
How the company first told customers
Letter

All recalls from Meitheal Pharmaceuticals, Inc

Timeline

FDA's Enforcement Report is its public list of recalls; FDA posts a recall by adding it there.

  1. Meitheal Pharmaceuticals began the recall

  2. FDA posted the recall to its Enforcement Report and rated it Class III (low risk)

  3. Added to Recall Canary

  4. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 31, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)